NPI: 1639143431 · PALM SPRINGS, CA 92262 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/16/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/16/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,884 | $769K |
| 2019 | 26,266 | $938K |
| 2020 | 22,697 | $889K |
| 2021 | 23,259 | $926K |
| 2022 | 22,029 | $1.19M |
| 2023 | 23,343 | $1.33M |
| 2024 | 13,536 | $1.44M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 50,685 | 4,343 | $7.36M |
| A4657 | Syringe, with or without needle, each | 3,995 | 2,105 | $107K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 45,015 | 3,215 | $5K |
| 82728 | 1,219 | 1,162 | $2K | |
| 90661 | 20 | 20 | $737.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 967 | 573 | $573.14 |
| J1756 | Injection, iron sucrose, 1 mg | 12,707 | 3,229 | $152.10 |
| 85041 | 1,863 | 1,752 | $0.00 | |
| 83970 | 1,746 | 1,607 | $0.00 | |
| 85048 | 1,847 | 1,740 | $0.00 | |
| 83540 | 1,281 | 1,198 | $0.00 | |
| 82108 | 45 | 43 | $0.00 | |
| 90662 | 14 | 14 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 31 | 13 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,447 | 1,940 | $0.00 |
| 83550 | 1,231 | 1,148 | $0.00 | |
| 0250 | 4,356 | 323 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 293 | 244 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 27 | 25 | $0.00 |
| 82746 | 43 | 41 | $0.00 | |
| 90674 | 137 | 133 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 45 | 43 | $0.00 |